67 related articles for article (PubMed ID: 24905093)
1. Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
Hortal M; Estevan M; Meny M; Iraola I; Laurani H
PLoS One; 2014; 9(6):e98567. PubMed ID: 24905093
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the incidence of hospitalization for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older.
Lyngstad TM; Kristoffersen AB; Winje BA; Steens A
Epidemiol Infect; 2022 Apr; 150():1-21. PubMed ID: 35373724
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in Canada.
McNeil SA; Qizilbash N; Ye J; Gray S; Zanotti G; Munson S; Dartois N; Laferriere C
Can Respir J; 2015 Dec; ():. PubMed ID: 26668826
[No Abstract] [Full Text] [Related]
4. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.
Moore MR; Link-Gelles R; Schaffner W; Lynfield R; Lexau C; Bennett NM; Petit S; Zansky SM; Harrison LH; Reingold A; Miller L; Scherzinger K; Thomas A; Farley MM; Zell ER; Taylor TH; Pondo T; Rodgers L; McGee L; Beall B; Jorgensen JH; Whitney CG
Lancet Infect Dis; 2015 Mar; 15(3):301-9. PubMed ID: 25656600
[TBL] [Abstract][Full Text] [Related]
5. Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease.
Ben-Shimol S; Greenberg D; Hazan G; Givon-Lavi N; Gottesman G; Grisaru-Soen G; Dagan R;
Pediatr Infect Dis J; 2015 Apr; 34(4):409-16. PubMed ID: 25764098
[TBL] [Abstract][Full Text] [Related]
6. All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.
Berglund A; Ekelund M; Fletcher MA; Nyman L
PLoS One; 2014; 9(11):e112211. PubMed ID: 25379659
[TBL] [Abstract][Full Text] [Related]
7. Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012.
Griffin MR; Mitchel E; Moore MR; Whitney CG; Grijalva CG;
MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(44):995-8. PubMed ID: 25375070
[TBL] [Abstract][Full Text] [Related]
8. Impact of the antipneumococcal conjugate vaccine on the occurrence of infectious respiratory diseases and hospitalization rates in children.
Abrão WM; Mello LM; Silva AS; Nunes AA
Rev Soc Bras Med Trop; 2015; 48(1):44-9. PubMed ID: 25860463
[TBL] [Abstract][Full Text] [Related]
9. The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation.
Stock NK; Maly M; Sebestova H; Orlikova H; Kozakova J; Krizova P
PLoS One; 2015; 10(6):e0131117. PubMed ID: 26125583
[TBL] [Abstract][Full Text] [Related]
10. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
[TBL] [Abstract][Full Text] [Related]
11. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
[TBL] [Abstract][Full Text] [Related]
12. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.
Scotta MC; Veras TN; Klein PC; Tronco V; Polack FP; Mattiello R; Pitrez PMC; Jones MH; Stein RT; Pinto LA
Vaccine; 2014 Jul; 32(35):4495-4499. PubMed ID: 24958703
[TBL] [Abstract][Full Text] [Related]
13. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children.
Olarte L; Barson WJ; Barson RM; Lin PL; Romero JR; Tan TQ; Givner LB; Bradley JS; Hoffman JA; Hultén KG; Mason EO; Kaplan SL
Clin Infect Dis; 2015 Sep; 61(5):767-75. PubMed ID: 25972022
[TBL] [Abstract][Full Text] [Related]
14. Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced.
Chang Q; Stevenson AE; Croucher NJ; Lee GM; Pelton SI; Lipsitch M; Finkelstein JA; Hanage WP
BMC Infect Dis; 2015 Feb; 15():68. PubMed ID: 25887323
[TBL] [Abstract][Full Text] [Related]
15. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
16. Decreased number of hospitalized children with severe acute lower respiratory infection after introduction of the pneumococcal conjugate vaccine in the Eastern Democratic Republic of the Congo.
Birindwa AM; Manegabe JT; Mindja A; Nordén R; Andersson R; Skovbjerg S
Pan Afr Med J; 2020; 37():211. PubMed ID: 33520050
[TBL] [Abstract][Full Text] [Related]
17. Determinants of Under-Five Pneumonia at Gondar University Hospital, Northwest Ethiopia: An Unmatched Case-Control Study.
Markos Y; Dadi AF; Demisse AG; Ayanaw Habitu Y; Derseh BT; Debalkie G
J Environ Public Health; 2019; 2019():9790216. PubMed ID: 31662768
[TBL] [Abstract][Full Text] [Related]
18. 12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin-resistant
Chacon-Cruz E; Rivas-Landeros RM; Volker-Soberanes ML; Lopatynsky-Reyes EZ; Becka C; Alvelais-Palacios JA
Ther Adv Infect Dis; 2019; 6():2049936119839312. PubMed ID: 30984396
[TBL] [Abstract][Full Text] [Related]
19. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.
Ouldali N; Levy C; Minodier P; Morin L; Biscardi S; Aurel M; Dubos F; Dommergues MA; Mezgueldi E; Levieux K; Madhi F; Hees L; Craiu I; Gras Le Guen C; Launay E; Zenkhri F; Lorrot M; Gillet Y; Béchet S; Hau I; Martinot A; Varon E; Angoulvant F; Cohen R
JAMA Pediatr; 2019 Apr; 173(4):362-370. PubMed ID: 30715140
[TBL] [Abstract][Full Text] [Related]
20. Vaccination herd effect experience in Latin America: a systematic literature review.
DeAntonio R; Amador S; Bunge EM; Eeuwijk J; Prado-Cohrs D; Nieto Guevara J; Rubio MDP; Ortega-Barria E
Hum Vaccin Immunother; 2019; 15(1):49-71. PubMed ID: 30230953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
